The most frequently reported adverse events (AEs) of GLP-1 RAs were gastrointestinal adverse drug reactions, including nausea, vomiting, and abdominal pain, which were closely related to activation of central and peripheral GLP-1 receptors ( In a recent network meta-analysis, overall GLP-1 RAs significantly increased the incidence of gastrointestinal AEs compared with placebo or conventional treatment, and the odds ratios for nausea, vomiting and diarrhea from GLP-1 RAs were 11.8 (95% CI, 2.8946.9), 51.7 (95% CI, 7.07415), and 4.93 (95% CI, 1.7514.7), respectively (1214)
The test identifies genetic predispositions in peptide and antioxidant pathways, including variants affecting cysteine metabolism and oxidative stress enzyme function
Standard oral glutathione has only 0.7% bioavailability but remains generally well-tolerated at recommended doses
For healthy adults, this is not a reason to panic
nudnoci, ziewanie/stretching, zmniejszenie apetytu) zgaszano czciej ni po placebo
This growth can be limited by senescence